What's new in allergic dermatitis and how does it impact clinical practice Andrew Hillier | Default



What's new in allergic dermatitis and how does it impact clinical practice

Duration: 0:54 h
Speaker: Andrew Hillier
from 1 US$ 46.20
(incl. tax)

Our understanding of allergic dermatitis in dogs has changed dramatically in the last 10 years. This presentation will highlight new information that changes the way we practice and will include insights on new definitions and clinical syndromes, pathophysiology of atopic dermatitis, a streamlined diagnostic approach and diagnostic criteria, new innovative treatments, and guidance for conducting food trials, amongst others.

This webinar is organised in co-operation with the South African Vet Dermatology Interest Group, sponsored by Virbac South Africa, and facilitated by Vet360

Recording from 08.08.2018


Andrew Hillier

Dr. Andrew Hillier BVSc, MANZCVS (Canine Medicine), Diplomate American College of Veterinary Dermatology

Dr. Andrew (“Andy”) Hillier is originally from South Africa where he graduated from the Faculty of Veterinary Science at the University of Pretoria, (Onderstepoort) in 1982. After 2 years military service, he was in small animal primary care practice for 8 years in South Africa (Cape Town) and Australia (Perth). Dr. Hillier completed a residency in veterinary dermatology at the University of Florida from 1992-1994 and became board certified by the American College of Veterinary Dermatology in 1994. Thereafter he established his own dermatology referral practice in Australia before heading back to the US in 1996 where he was on faculty at The Ohio State University for 17 years, becoming a Full Professor and Head of the Dermatology + Otology Service. He left Ohio State in May 2013 to join Zoetis as a Senior Veterinary Specialist. Dr. Hillier has published over 40 peer-reviewed articles, edited and written books and book chapters, and lectured extensively both in the US and internationally. His primary areas of interest are staphylococcal pyoderma, antimicrobial drugs, atopic dermatitis, otitis and demodicosis.

You might also be interested in